Does nose spray addiction exist? A qualitative analysis of addiction components in rhinitis medicamentosa
- PMID: 39932504
- PMCID: PMC11974400
- DOI: 10.1556/2006.2024.00078
Does nose spray addiction exist? A qualitative analysis of addiction components in rhinitis medicamentosa
Abstract
Background and aims: Nasal congestion is a prevalent symptom often alleviated with over-the-counter nasal sprays containing decongestants. Rhinitis medicamentosa (RM), caused by the overuse of decongestants leading to recurrent mucosal swelling, poses a significant challenge for specialists in managing patients. Despite advancements in understanding, research primarily consists of case series with limited data on its impact on quality of life. This qualitative study aimed to explore the effect of nasal spray overuse on quality of life and identify addiction components among individuals with RM.
Methods: Twenty participants with RM were interviewed by an otorhinolaryngologist and addiction counsellor. The study employed a qualitative approach utilising directed content analysis and revealed eleven categories, classified into addiction components and distinctive features of nasal spray addiction.
Results: The analysis revealed the presence of all Griffiths' addiction components in the identified themes. Additionally, sleep disorders, the feeling of suffocation, side effects, illness identity and psychological effects on nasal congestion significantly impair individuals' quality of life.
Conclusion: This qualitative study identified key components of addiction in nasal spray overuse and suggested that RM might be conceptualised in the DSM-5 category of "Other (or Unknown) Substance-Related Disorders", considering the lack of psychoactive effects. Nevertheless, in view of the current findings, it also seems to be plausible to examine the phenomenon in the behavioural addiction framework. The study underscores the need for further research and intervention strategies to address the significant impact of RM on individuals' quality of life.
Keywords: addiction; content analysis; nasal decongestant; qualitative; rhinitis medicamentosa.
Conflict of interest statement
Figures
Similar articles
-
[Clinical review of 33 cases of rhinitis medicamentosa by decongestant nasal spray].Arerugi. 2013 Dec;62(12):1623-30. Arerugi. 2013. PMID: 24608651 Japanese.
-
One-week use of oxymetazoline nasal spray in patients with rhinitis medicamentosa 1 year after treatment.ORL J Otorhinolaryngol Relat Spec. 1997 Jan-Feb;59(1):39-44. doi: 10.1159/000276903. ORL J Otorhinolaryngol Relat Spec. 1997. PMID: 9104748
-
Topical hyaluronic acid in rhinitis medicamentosa: could our perspective be changed?J Biol Regul Homeost Agents. 2017 Dec 27;31(4 Suppl 2):55-62. J Biol Regul Homeost Agents. 2017. PMID: 29202563 Clinical Trial.
-
Rhinitis medicamentosa.Ugeskr Laeger. 2024 Sep 2;186(36):V04240252. doi: 10.61409/V04240252. Ugeskr Laeger. 2024. PMID: 39320073 Review. Danish.
-
Rhinitis medicamentosa.J Investig Allergol Clin Immunol. 2006;16(3):148-55. J Investig Allergol Clin Immunol. 2006. PMID: 16784007 Review.
References
-
- Akerlund, A., & Bende, M. (1991). Sustained use of xylometazoline nose drops aggravates vasomotor rhinitis. American Journal of Rhinology & Allergy, 5(4), 157–160. 10.2500/105065891781874983. - DOI
-
- American Psychiatric Association . (2022). Diagnostic and statistical manual of mental disorders: DSM-5-TR (5th ed.). Washington, DC: American Psychiatric Association Publishing. 10.1176/appi.books.9780890425787. - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical